Global Simple Peptide Market Trends: Brand Comparison, Tech Pros/Cons & Selection Guide
Abstract: The global simple peptide market is projected to reach $XX billion by 2030 (CAGR 8.5%), driven by anti-aging demand. This guide compares top brands (e.g., The Ordinary vs. NIOD) on purity, stability, and cost. Key tech pros include high bioavailability; cons involve enzymatic degradation. Selection criteria emphasize COA certificates, factory GMP compliance, and logistics (cold chain). Industry trends favor multi-functional sequences, while regulatory shifts (FDA/EFSA) reshape brand status.